Efficacy News and Research

RSS

Semaglutide reduces heart risks in overweight and obese individuals without diabetes

The SELECT trial found that semaglutide significantly reduces cardiovascular events in individuals with overweight or obesity and preexisting cardiovascular disease, regardless of baseline HbA1c or changes in HbA1c levels.

26 Jun 2024

Extended-release ketamine tablets offer new hope for treatment-resistant depression

The BEDROC trial found that extended-release ketamine tablets (R-107) significantly improve depressive symptoms in treatment-resistant depression patients, with the 180 mg dose showing the most efficacy. The treatment was well-tolerated with minimal side effects.

26 Jun 2024

AI transforming cardiovascular care with groundbreaking diagnostic and prognostic innovations

AI tools are revolutionizing cardiovascular healthcare by enhancing diagnostics, prognostics, and biomarker detection, thus improving the precision and efficacy of care. The review also addresses the potential risks and challenges in integrating AI into clinical workflows.

25 Jun 2024

Comparative study on preventative SMA therapies shows mixed outcomes

In a first-of-its-kind study, researchers compared the efficacy of preventative therapy for spinal muscular atrophy (SMA) between two well-matched study groups, using either gene therapy (onasemnogene abeparvovec) alone or in combination with risdiplam (oral medication) or nusinersen (intrathecal injection) administered before apparent signs of disease emerged.

25 Jun 2024

New curative treatment for sickle cell disease shows promising results in international trial

Vanderbilt University Medical Center (VUMC) researchers are touting data from a multicenter, international phase 2 clinical trial showing a new, curative treatment for sickle cell disease (SCD).

25 Jun 2024

New ULTRA-PTT technology enhances the performance of conventional photothermal therapy

Professor Jin-ho Chang's research team from the Department of Electrical Engineering and Computer Science at DGIST (President Kun-woo Lee) developed "Ultrasound-assisted photothermal therapy (ULTRA-PTT)" technology that significantly enhances the performance of conventional photothermal therapy.

25 Jun 2024

WHO report highlights global burden of alcohol and drug-related deaths

A new report from the World Health Organization (WHO) highlights that 2.6 million deaths per year were attributable to alcohol consumption, accounting for 4.7% of all deaths, and 0.6 million deaths to psychoactive drug use.

25 Jun 2024

New MDMA variants could be promising alternatives for safe psychotherapeutic applications

The use of the active ingredient 3,4-methylenedioxy-N-methylamphetamine (MDMA), commonly known as "ecstasy", to support psychotherapy for mental illnesses such as post-traumatic stress disorder is being discussed worldwide.

25 Jun 2024

Positive emotion skills improve health care workers' well-being

The COVID-19 pandemic exacerbated already rising rates of burnout among American health care workers.

24 Jun 2024

Bridging knowledge and confidence to increase skin self-examinations

It's summer and time to enjoy the sunshine. But it's also important to do so safely. Skin cancer is the most common form of cancer in the United States - and it's most commonly caused by sun exposure.

24 Jun 2024

“Induced” learning and implementation of AHA/ASA best practices speed up stroke care

West Virginia University research illustrates that American Heart Association and American Stroke Association guidelines are effective at speeding up hospitals' response times for stroke treatment and can be mastered even by members of "ad hoc" medical teams that assemble rapidly on the fly.

24 Jun 2024

New study reveals the therapeutic potential of ZED1227 in celiac disease

A recent study led by researchers at Tampere University investigated whether a transglutaminase 2 inhibitor has potential as a drug to treat celiac disease.

24 Jun 2024

Electrophysiological markers for personalizing transcranial magnetic stimulation in depression

Not all patients with depression respond to medication. Two recently published studies provide additional information on how an alternative treatment, transcranial magnetic stimulation (TMS), could be further enhanced.

24 Jun 2024

Dietary sucrose modulates lithium's regulatory activity in Drosophila

A new research paper was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) Volume 16, Issue 11, entitled, "Dietary sucrose determines the regulatory activity of lithium on gene expression and lifespan in Drosophila melanogaster."

24 Jun 2024

Semaglutide provides double benefit for women with heart failure

Semaglutide, a medication initially developed for type 2 diabetes and obesity, significantly improves symptoms in men and women with a common type of heart failure that has had few therapeutic options.

24 Jun 2024

Will it soon be possible for doctors to use AI to detect and diagnose cancer?

Researchers developed binary and multiclass machine learning models to distinguish cancer from non-cancerous tissue samples.

24 Jun 2024

Walking and education intervention significantly reduces recurrence of low back pain

Researchers conducted a randomized controlled trial to determine the clinical efficacy and cost-efficiency of the WalkBack personalized, walking, and educational intervention program in preventing lower backache recurrence among Australians.

24 Jun 2024

Intermittent fasting outperforms traditional drugs in managing early type 2 diabetes

Study shows that a 5:2 intermittent fasting meal replacement diet effectively controls blood glucose levels and reduces body weight in Chinese adults with early type 2 diabetes. This dietary intervention outperforms metformin and empagliflozin in managing diabetes and obesity.

24 Jun 2024

Mindfulness meditation curbs gaming addiction by altering brain responses

Mindfulness meditation significantly reduces gaming cravings and addiction severity in adults with Internet Gaming Disorder. The study reveals decreased activation in brain regions associated with craving, such as the lentiform nuclei and medial frontal gyrus.

23 Jun 2024

Novo Nordisk presents key findings from semaglutide trials at ADA scientific sessions 2024

Novo Nordisk today announced the presentation of 34 abstracts highlighting the breadth of its portfolio at the upcoming 84th Scientific Sessions of the American Diabetes Association (ADA).

22 Jun 2024

Efficacy News and Research

Semaglutide reduces heart risks in overweight and obese individuals without diabetes

Extended-release ketamine tablets offer new hope for treatment-resistant depression

AI transforming cardiovascular care with groundbreaking diagnostic and prognostic innovations

Comparative study on preventative SMA therapies shows mixed outcomes

New curative treatment for sickle cell disease shows promising results in international trial

New ULTRA-PTT technology enhances the performance of conventional photothermal therapy

WHO report highlights global burden of alcohol and drug-related deaths

New MDMA variants could be promising alternatives for safe psychotherapeutic applications

Positive emotion skills improve health care workers' well-being

Bridging knowledge and confidence to increase skin self-examinations

“Induced” learning and implementation of AHA/ASA best practices speed up stroke care

New study reveals the therapeutic potential of ZED1227 in celiac disease

Electrophysiological markers for personalizing transcranial magnetic stimulation in depression

Dietary sucrose modulates lithium's regulatory activity in Drosophila

Semaglutide provides double benefit for women with heart failure

Will it soon be possible for doctors to use AI to detect and diagnose cancer?

Walking and education intervention significantly reduces recurrence of low back pain

Intermittent fasting outperforms traditional drugs in managing early type 2 diabetes

Mindfulness meditation curbs gaming addiction by altering brain responses

Novo Nordisk presents key findings from semaglutide trials at ADA scientific sessions 2024

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News